[PDF][PDF] Human trials of stem cell-derived dopamine neurons for Parkinson's disease: dawn of a new era
Stem cell-based therapies for Parkinson's disease are moving into a new and exciting era,
with several groups pursuing clinical trials with pluripotent stem cell (PSC)-derived
dopamine neurons. As many groups have ongoing or completed GMP-level cell
manufacturing, we highlight key clinical translation considerations from our recent fourth
GForce-PD meeting.
with several groups pursuing clinical trials with pluripotent stem cell (PSC)-derived
dopamine neurons. As many groups have ongoing or completed GMP-level cell
manufacturing, we highlight key clinical translation considerations from our recent fourth
GForce-PD meeting.
Summary
Stem cell-based therapies for Parkinson's disease are moving into a new and exciting era, with several groups pursuing clinical trials with pluripotent stem cell (PSC)-derived dopamine neurons. As many groups have ongoing or completed GMP-level cell manufacturing, we highlight key clinical translation considerations from our recent fourth GForce-PD meeting.
cell.com